CRH Medical Corp (AMEX:CRHM) was upgraded by analysts at National Bank Financial from a “sector perform” rating to an “outperform” rating in a research note issued to investors on Friday.

A number of other analysts also recently commented on the stock. TD Securities downgraded shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. CIBC downgraded shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a report on Monday, July 17th.

Shares of CRH Medical Corp (AMEX CRHM) traded down 14.04% on Friday, reaching $2.45. 293,681 shares of the company were exchanged. CRH Medical Corp has a 52-week low of $2.45 and a 52-week high of $9.25. The stock has a 50 day moving average of $4.77 and a 200-day moving average of $6.37.

COPYRIGHT VIOLATION WARNING: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/06/crh-medical-corp-amexcrhm-upgraded-to-outperform-by-national-bank-financial.html.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.